OCT News and Research

RSS

Researchers examine immune responses to CRISPR-Cas9 gene editing system

The CRISPR-Cas9 gene editing system has been generating excitement within the field of gene therapy, inspiring hopes of molecular tools capable of treating genetic diseases.

30 Oct 2018

GOP’s latest campaign punch on health care relies on classic hook: Medicare

Once again, Medicare is front and center in this fall's campaigns. Democrats throughout the election season have been hammering Republicans over votes and lawsuits that would eliminate insurance protections for preexisting conditions for consumers.

30 Oct 2018

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

Nanoparticles that could reprogram a cancer patient's immune system inside their own body. Understanding a mysterious type of brain cell in the hopes of shedding new light on Alzheimer's disease. Reimagining nuclei, the DNA-storage compartments of our cells, as miniature lava lamps.

30 Oct 2018

LKSOM and Hunter jointly receive $13.5 million grant from National Cancer Institute

The Lewis Katz School of Medicine at Temple University and Hunter College of the City University of New York have jointly received a five-year, $13.5 million grant from the National Cancer Institute.

30 Oct 2018

Scientists find high levels of previously unsuspected pollutant in homes, environment

Scientists at Indiana University found high levels of a previously unsuspected pollutant in homes, in an electronic waste recycling facility and in the natural environment. People are likely to be exposed to this pollutant by breathing contaminated dust or through skin contact.

30 Oct 2018

Promising potential of stimuli-responsive nanomaterial for cancer therapy

Nanosystems that deliver anticancer drugs or imaging materials to tumors are showing significant progress, particularly those that respond to tumor-related stimuli, according to a review published in the journal Science and Technology of Advanced Materials.

30 Oct 2018

Type of alleged crime can increase jurors' confidence in guilt, finds new study

The more severe a crime, the more evidence you should have to prove someone did it. But a new Duke study, appearing Oct. 29 in Nature Human Behavior, has shown that the type of alleged crime can increase jurors' confidence in guilt.

30 Oct 2018

Study finds increased risks to mother and baby when pregnancies are closely spaced

Twelve to 18 months seems to be the ideal length of time between giving birth and getting pregnant again, according to new research from the University of British Columbia and the Harvard T.H. Chan School of Public Health.

29 Oct 2018

Studies show that non-invasive imaging can detect Alzheimer's disease

Results from two studies show that a new, non-invasive imaging device can see signs of Alzheimer's disease in a matter of seconds. The researchers show that the small blood vessels in the retina at the back of the eye are altered in patients with Alzheimer's.

29 Oct 2018

Common diabetes medication may protect against age-related macular degeneration

Researchers from Taiwan have shown that people with type 2 diabetes who took a common diabetes medication, metformin, had a significantly lower rate of age-related macular degeneration.

29 Oct 2018

Home blood pressure measurements can be used to diagnose hypertension in U.S. adults

Blood pressure readings of 130/80 millimeters of mercury (mm Hg) or higher taken at home can be used to diagnose hypertension in white, black and Hispanic U.S. adults, according to new research in the American Heart Association's journal Hypertension.

29 Oct 2018

Experimental vaccine shows promise to protect stroke survivors from blood clots

A vaccine may one day be able to replace oral blood thinners to reduce the risk of secondary strokes caused by blood clots, without increasing the risk of serious bleeding or triggering an autoimmune response, according to new research in the American Heart Association's journal Hypertension.

29 Oct 2018

Dialysis giant Davita defends itself in court and at the polls

It's been a year of playing defense for DaVita Inc., one of the country's largest dialysis providers.

29 Oct 2018

Study finds kill code mechanism embedded in every cell to extinguish cancer

A kill code is embedded in every cell in the body whose function may be to cause the self-destruction of cells that become cancerous, reports a new Northwestern Medicine study. As soon as the cell's inner bodyguards sense it is mutating into cancer, they punch in the kill code to extinguish the mutating cell.

29 Oct 2018

That’s a lot of scratch: The $48,329 allergy test

Janet Winston had a rash that wouldn't go away. The English professor from Eureka, Calif., always had been sensitive to ingredients in skin creams and cosmetics. This time, however, the antifungal cream she was prescribed to treat her persistent rash seemed to make things worse. Was she allergic to that, too?

29 Oct 2018

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Biogen and Eisai Co., Ltd. announced that Biogen presented results at the Clinical Trials on Alzheimer's Disease meeting, in Barcelona, Spain, from the recent 36- and 48-month analyses of the ongoing long-term extension of the Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD.

29 Oct 2018

Novartis enters into clinical development agreement with Pfizer to improve treatment of NASH

Novartis announced today that it has entered into a clinical development agreement with Pfizer which will include a study combining tropifexor and one or more Pfizer compounds for the treatment of NASH, including an Acetyl CoA-Carboxylase (ACC) Inhibitor (PF-05221304, a Diacylglycerol O-Acyltransferase 2 (DGAT2) Inhibitor (PF-06865571, and a Ketohexokinase (KHK) Inhibitor (PF-06835919).

29 Oct 2018

Getting right level of leptin may help protect cardiovascular health

Like that famous bowl of porridge, when leptin levels are "just right" they help protect our cardiovascular health, scientists say.

29 Oct 2018

Ischemia-induced stem cells can be promising candidates for CNS injury therapeutics

Researchers have performed a careful comparison between locally generated, ischemia-induced, multipotent stem cells and bone marrow-derived mesenchymal stem cells in an effort to determine which cell type has greater central nervous system repair capacity.

26 Oct 2018

New resource outlines neurologic effects and treatment options for biologic, chemical attacks

The neurologic effects and treatment options for exposure to biologic and chemical agents are outlined in a newly published article by neurologists from the University of Colorado School of Medicine who collaborated on the article with military physicians.

26 Oct 2018

OCT News and Research

Researchers examine immune responses to CRISPR-Cas9 gene editing system

GOP’s latest campaign punch on health care relies on classic hook: Medicare

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

LKSOM and Hunter jointly receive $13.5 million grant from National Cancer Institute

Scientists find high levels of previously unsuspected pollutant in homes, environment

Promising potential of stimuli-responsive nanomaterial for cancer therapy

Type of alleged crime can increase jurors' confidence in guilt, finds new study

Study finds increased risks to mother and baby when pregnancies are closely spaced

Studies show that non-invasive imaging can detect Alzheimer's disease

Common diabetes medication may protect against age-related macular degeneration

Home blood pressure measurements can be used to diagnose hypertension in U.S. adults

Experimental vaccine shows promise to protect stroke survivors from blood clots

Dialysis giant Davita defends itself in court and at the polls

Study finds kill code mechanism embedded in every cell to extinguish cancer

That’s a lot of scratch: The $48,329 allergy test

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Novartis enters into clinical development agreement with Pfizer to improve treatment of NASH

Getting right level of leptin may help protect cardiovascular health

Ischemia-induced stem cells can be promising candidates for CNS injury therapeutics

New resource outlines neurologic effects and treatment options for biologic, chemical attacks

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News